Neuroscience Technologies
Brain–computer interfaces and neural enhancement systems, assessed for clinical validity and commercial viability.
Advanced Technology Research
Advancing BeyondConventional Limits
Pinnacle evaluates advanced technologies emerging from government research programs and defines safe, accountable pathways to commercial application — sustaining U.S. competitive advantage without outpacing the safeguards.
NeuroscienceNeural interface systems
Mental HealthTherapeutic technologies
RoboticsHuman augmentation
TransitionGovernment to commercial
Research Focus
Advanced Technology Development
Our work concentrates on three technology families where the gap between demonstrated government capability and commercial readiness is widest — and where getting the transition wrong carries the highest cost.
Mental Health Systems
Intervention and therapeutic technologies with the potential to change the standard of care at scale.
Robotic Systems
Human augmentation and specialized robotics for medical, industrial, and field deployment.
Controlled Development
Every assessment runs under defined safety protocols with appropriate security review at each stage.
Research Approach
We evaluate advanced technologies originating in government research programs and determine whether — and how — they can be deployed commercially without compromising safety or strategic advantage.
Working across neuroscience, mental health, and robotics, our team applies consistent review protocols to each candidate technology, so that breakthroughs reach the market on terms the public can live with.
Read the assessment methodologyPotential Applications
-
01
Healthcare Applications
Neural interfaces and mental health technologies applied to therapeutic care.
-
02
Human Augmentation
Robotic systems that extend human capability in medical and industrial settings.
-
03
Commercial Transition
Structured hand-off of advanced technology into competitive commercial products.
Research Publications
Latest Research & Reports
Our published work covers neuroscience technologies, mental health systems, and robotic applications, with emphasis on safe commercial deployment and transition planning.
Advanced Technology Transition: Strategic Assessment for Commercial Applications
Executive summary and technology overview
An analysis of advanced neuroscience, mental health, and robotic technologies with near-term potential for commercial deployment — including strategic assessment, controlled development protocols, and recommendations for safe transition.
Research Overview
Core technology areas and capabilities
- Neural interface technologies
- Mental health intervention systems
- Advanced robotic applications
- Human augmentation technologies
- Controlled development protocols
Development Roadmap
A phased, evidence-gated approach
- Phase 1 — Technology evaluation (0–12 months)
- Phase 2 — Controlled testing (12–36 months)
- Phase 3 — Commercial deployment (36–60 months)
- Government collaboration framework
- Technology transfer protocols
Strategic Applications
Where the work lands
- Healthcare and therapeutic systems
- Industrial automation integration
- Human performance enhancement
- Strategic technology advantage
- Structured technology transfer
Additional Resources
Patent Documentation
Foundational intellectual property covering neural interfaces, mental health systems, and robotic applications.
Request patent abstractTechnical Whitepaper
Full technical documentation: neuroscience principles, engineering specifications, and safety validation protocols.
Request accessRestricted materials
Full technical documentation and the complete assessment are released to verified partners and collaborators. Send a request through the form below and our team will respond with access details and any applicable review requirements.
Leadership
Board of Directors
Our leadership combines technical depth with strategic oversight, so that technology transition stays both responsible and competitive.
—
[Board Member Name]
Lead Board Member
Strategic leadership in advanced technology transition, with experience across government and commercial technology partnerships.
IM
Ian Franklin McLean
Board Member
Researcher in advanced neuroscience and robotic systems. Patent holder with expertise in technology evaluation and commercial deployment strategy.
—
[Board Member Name]
Board Member
Expertise in mental health technologies and regulatory affairs, focused on compliant deployment and review protocols.
Note for the editor: replace the two [Board Member Name] placeholders,
their roles, bios and initials once the board is confirmed. Each card lives in the
#team section of index.html.
Get in Touch
Contact Pinnacle Institute
Interested in research collaboration, technology assessment, or a commercial partnership? Reach out and our team will follow up directly.
Collaboration Request
Tell us about your organization and what you are looking to explore.
Direct Contact
Reach the leadership team
Ian Franklin McLeanBoard Member — technology assessment
Strategic BriefingsScheduled on request
Newport Beach, CaliforniaMeetings by appointment
Partnership Opportunities
Government & Strategic Partners
Technology assessment supporting national technological leadership.
Commercial Partners
Robotics manufacturers and technology integrators.
Research Institutions
Academic collaboration and independent validation studies.
Ready for a strategic briefing?
The technologies we assess represent real breakthroughs — and real responsibility. Partner with us on a transition that is competitive and defensible.
Request Strategic Briefing